Ignite Creation Date:
2024-05-06 @ 8:14 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06303193
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-15
First Post:
2024-03-08
Brief Title:
Pacritinib a Kinase Inhibitor of CSF1R IRAK1 JAK2 and FLT3 in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or MyelodysplasticMyeloproliferative Neoplasms
Sponsor:
National Cancer Institute NCI
Organization:
National Institutes of Health Clinical Center CC
Organization Data
Organization:
National Institutes of Health Clinical Center CC
Class:
NIH
Study ID:
10001554
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
National Cancer Institute NCI
Lead Sponsor Class:
NIH
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None